The global animal model market was valued at USD 2.54 billion in 2024 and is expected to grow to USD 2.76 billion in 2025, reaching approximately USD 5.81 billion by 2034. This growth reflects a compound annual growth rate (CAGR) of 8.64% between 2025 and 2034. The market is being driven by increasing research and development activities, a rise in chronic diseases, and higher investments in biomedical research.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5390
Animal models are non-human species used in biomedical research to replicate aspects of human diseases or biological processes. These animals, including mice, rats, guinea pigs, zebrafish, monkeys, and dogs, are chosen based on how closely their biology mirrors that of humans. They are essential in studying diseases and testing potential treatments, especially when human testing is not feasible or ethical.
The growing prevalence of chronic diseases, largely due to an aging population, is pushing the need for new treatments. This is encouraging more research and development in labs around the world. Regulatory agencies also play a role by requiring preclinical trial data, often involving animal models, before human trials can proceed. Moreover, increased funding and collaborations in the field are further fueling the market’s expansion.
The animal model market is experiencing significant growth, driven by various trends that are shaping its future. These trends highlight the importance of animal models in advancing biomedical research and the development of new treatments. Here are some key trends in the animal model market:
With advancements in genetic engineering, genetically modified animals are becoming increasingly popular in research. These models, such as transgenic mice, offer more accurate simulations of human diseases and genetic conditions, enhancing the precision of preclinical studies.
The shift toward personalized medicine is prompting researchers to develop more tailored and specific animal models. By replicating individual genetic variations, these models are helping to improve drug development processes and better predict patient responses to treatments.
As regenerative medicine and stem cell research continue to grow, there is an increasing need for animal models to test new therapies. These models help researchers understand how stem cells behave in living organisms and assess the safety and efficacy of new treatments.
While traditional animal models like mice and rats remain prevalent, there is a rising interest in alternative animal models, including zebrafish, pigs, and non-human primates. These models offer unique advantages, such as more complex biological systems or better mimicking of human diseases, broadening the scope of research.
Collaborations between pharmaceutical companies, research organizations, and academic institutions are increasing. These partnerships are driving investments into animal model-based research, which, in turn, supports the development of innovative treatments for chronic diseases, cancer, and neurological disorders.
Technological innovations, such as 3D printing, AI, and organ-on-a-chip models, are providing new methods for more accurate and humane animal testing. These technologies allow for better simulation of human biology, reducing the reliance on traditional animal models while enhancing the overall quality of research.
Regulations surrounding animal testing are becoming stricter, with increasing focus on ethical considerations. This has led to the development of guidelines and frameworks that promote the use of alternatives to animal testing where possible, while ensuring the continued use of animal models where they are crucial for advancing science.
The increasing focus on healthcare and medical research, particularly in emerging markets, is driving the demand for animal models. As governments and private investors invest more in R&D activities, the market for animal models is expected to expand further.
These trends indicate that the animal model market will continue to evolve, with an emphasis on technological innovation, regulatory improvements, and a greater focus on ethically sound research practices.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/animal-model-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5390
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The AI in cancer drugs market is on a remarkable growth path, poised to generate substantial revenue between 2025 and… Read More
The global biostimulants market is on a steady rise. Valued at USD 3.06 billion in 2024, it's expected to grow… Read More
The dental insurance market is booming. In 2024, it was valued at $232.07 billion, grew to $253.72 billion in 2025,… Read More
The global market for bipolar disorder treatments was valued at USD 9.74 billion in 2025 and is projected to grow… Read More
The global polio vaccine market is growing steadily and is expected to rise from USD 904.57 million in 2025 to… Read More
The global market for specialty medical chairs is on the rise. Valued at USD 5.12 billion in 2025, it's projected… Read More